Business Wire

Amadeus and Sigfox Partner to Transform the Travel Industry’s Tracking Capabilities

26.11.2019 14:56:00 EET | Business Wire | Press release

Share

Sigfox, the world’s leading Internet of Things (IoT) service provider and first global 0G network operator and Amadeus, the leading provider of IT solutions for the travel and tourism industry, announce a new strategic partnership at Sigfox Connect 2019. The agreement results from a year-long collaboration investigating business opportunities within the travel industry and developing a portfolio of solutions that will not only help meet the growing need for efficient asset tracking solutions, but also reduce operational challenges for airports and airlines.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191126005416/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

PinPoint, an Amadeus and Sigfox strategic alliance (Photo: Sigfox)

The unique combination of Sigfox IoT expertise and Amadeus’ in-depth travel industry knowledge sees the emergence of disruptive services that will hit the market in 2020 thanks to the Sigfox and Amadeus strategic alliance, called PinPoint.

PinPoint aims at providing best-in-class end-to-end tracking solution for the air transportation industry. It targets indeed initially airports and airlines with trackers optimally designed - connected and communicating through the Sigfox 0G global network and managed through the PinPoint platform.

Every year, airports and airlines handle billions of pieces of luggage and high-value assets which are often lost, damaged or delayed leading to high financial losses for the whole value chain, a lack of operational efficiency, and increasing dissatisfaction for travelers. Meanwhile, existing tracking technologies require expensive infrastructure updates, such as gates and readers and provide limited interoperability and geolocation capabilities. In parallel, regulation is increasingly demanding, especially the new IATA Resolution 753 on luggage tracking which imposes stricter tracking and increased visibility requirements to reduce luggage loss rates.

With this in mind, PinPoint aims to provide a new journey for travel industry assets through reusable, cost and energy-efficient, and globally connected trackers that offer airports and airlines access to real-time information about the location of luggage and high value assets, such as spare-parts, landing gear, Unit Load Devices (ULD) and much more.

Through reusable tags placed on luggage, proximity sensors installed across airports and Sigfox global coverage, airlines will be able to monitor luggage, accurately tracking its location and detecting anomalies. For high-value assets such as ULDs, airlines will be able to use this technology to collect data, enabling ULDs to report any movement, so optimizing ULD management and significantly reducing the risk of loss.

Sigfox Bubble technology, an innovative beaconing solution enabling proximity detection, will also be developed and deployed in collaboration with Sigfox new partner Alps Alpine, one of the world’s foremost manufacturers of electronics components. By managing the emission power, Sigfox Cloud adapts the range of the Bubble, from less than one meter to a few tens of meters, improving the accuracy of the device’s location. Thus, when entering a Bubble cell, Sigfox devices and associated assets share their identification to the cloud providing a highly accurate location for each asset.

“We are delighted to strengthen our partnership with Amadeus and share our combined expertise to create real digital transformation of the travel sector. Our strategic alliance named PinPoint will not only help to improve the travel experience, but this will also change completely the game for an industry looking for decades for THE technology able to save costs while improving efficiency and quality of services”, explains Raouti Chehih, Chief Adoption Officer at Sigfox.

“Sigfox technology is unique in its ability to track objects seamlessly across the globe, and at such a low cost. Combining Amadeus expertise and partners’ network in travel with Sigfox technology, we can enable luggage tracking at a price which is within what consumers are ready to pay for, and thus bring peace of mind to billions of travelers.” Marion Mesnage, Head of Research, Innovation & Ecosystems, Amadeus.

This new solution leverages Sigfox IoT expertise and unique 0G network while harnessing Amadeus trusted relationships within the travel industry to reduce costs for airlines and airports, deliver higher operational efficiency, generate ancillary revenues, and increase customer satisfaction.

This alliance, which aims in time to become a joint venture, is the starting point of a new journey that could revolutionize the travel industry. Although airports and airlines are the main targets today, in the future, Sigfox and Amadeus aspire to reach out to new sectors like hospitality to offer end-to-end tracking solutions that will cover the full traveler journey.

About Sigfox
Sigfox is the initiator of the 0G network and the world’s leading IoT (Internet of Things) service provider. Its global network allows billions of devices to connect to the Internet, in a straightforward way, while consuming as little energy as possible. Sigfox’s unique approach to device-to-cloud communications addresses the three greatest barriers to global IoT adoption: cost, energy consumption and global scalability.

Today, the network is available in 65 countries, with 1 billion people covered. ISO 9001 certified and surrounded by a large ecosystem of partners and IoT key players, Sigfox empowers companies to move their business model towards more digital services, in key areas such as Asset Tracking and Supply Chain. Founded in 2010 by Ludovic Le Moan and Christophe Fourtet, the company is headquartered in France and has offices in Madrid, Munich, Boston, Dallas, San Jose, Dubai, Singapore, Sao Paulo and Tokyo.

About Amadeus
Travel powers progress. Amadeus powers travel. Amadeus’ solutions connect travelers to the journeys they want through travel agents, search engines, tour operators, airlines, airports, hotels, cars and railways.
We have developed our technology in partnership with the travel industry for over 30 years. We combine a deep understanding of how people travel with the ability to design and deliver the most complex, trusted, critical systems our customers need. We help connect over 1.6 billion people a year to local travel providers in over 190 countries.
We are one company, with 19,000 employees across 70 offices. We have a global mindset and a local presence wherever our customers need us.
Our purpose is to shape the future of travel. We are passionate in our pursuit of better technology that makes better journeys.
Amadeus is an IBEX 35 company, listed on the Spanish Stock Exchange under AMS.MC. The company is also part of the EuroStoxx50 and has been recognized by the Dow Jones Sustainability Index for the last eight years.
To find out more about Amadeus, visit www.amadeus.com.
Follow us on:  Facebook /  Twitter /  LinkedIn /  YouTube /  Site web Amadeus

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Media
Sigfox
Antoine Mège, PR & Content Manager
antoine.mege@sigfox.com

Archetype for Sigfox
Rémi Fresnel
remi.fresnel@archetype.co
+33 (0)6 78 26 96 75

Amadeus
Bertrand Cognard, Corporate Communications
Bertrand.cognard@amadeus.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 11:15:00 EEST | Press release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to disease biology is translating into meaningful clinical progress. Our GPC3 x 4-1BB bispecific antibody continues to be well tolerated and demonstrates durable activity with longer follow up in patients with heavily pre-treated hepatocellular carcinoma, while the first clinical data from our brain-penetrant PRMT5 inhibitor and CEA-targeting ADC expand our innovation in non-small cell lung cancer. Alongsi

Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 20:42:00 EEST | Press release

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (

Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 17:19:00 EEST | Press release

Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com

BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 17:15:00 EEST | Press release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta

inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 16:00:00 EEST | Press release

inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye